A detailed history of Advisors Asset Management, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 12,661 shares of CORT stock, worth $710,155. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,661
Previous 9,764 29.67%
Holding current value
$710,155
Previous $317,000 84.54%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$29.51 - $46.26 $85,490 - $134,015
2,897 Added 29.67%
12,661 $585,000
Q2 2024

Aug 14, 2024

BUY
$22.21 - $34.48 $92,771 - $144,022
4,177 Added 74.76%
9,764 $317,000
Q1 2024

May 14, 2024

BUY
$21.1 - $27.46 $106,660 - $138,810
5,055 Added 950.19%
5,587 $140,000
Q4 2023

Feb 14, 2024

BUY
$24.82 - $32.88 $13,204 - $17,492
532 New
532 $17,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.01B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.